The latest research study released by Market IntelliX evaluates market size and forecasts of AI Medicine Software in Global, including the following market information:
Global AI Medicine Software Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global AI Medicine Software market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnosis Processes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of AI Medicine Software include Enlitic, Atomwise, DeepMind, Babylon Health, Flatiron Health, Tempus Labs, Sophia Genetics, Recursion Pharmaceuticals and Synyi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the AI Medicine Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global AI Medicine Software Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global AI Medicine Software Market Segment Percentages, by Type, 2021 (%)
Diagnosis Processes
Treatment Protocol Development
Drug Development
Personalized Medicine
Patient Monitoring and Care
Global AI Medicine Software Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global AI Medicine Software Market Segment Percentages, by Application, 2021 (%)
Hospital
Laboratory
Others
Global AI Medicine Software Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global AI Medicine Software Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI Medicine Software revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies AI Medicine Software revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Enlitic
Atomwise
DeepMind
Babylon Health
Flatiron Health
Tempus Labs
Sophia Genetics
Recursion Pharmaceuticals
Synyi
Freenome
GNS Healthcare
Olive
Ada Health
Clarify Health Solutions
Sight Diagnostics
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 AI Medicine Software Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AI Medicine Software Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AI Medicine Software Overall Market Size
2.1 Global AI Medicine Software Market Size: 2021 VS 2028
2.2 Global AI Medicine Software Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top AI Medicine Software Players in Global Market
3.2 Top Global AI Medicine Software Companies Ranked by Revenue
3.3 Global AI Medicine Software Revenue by Companies
3.4 Top 3 and Top 5 AI Medicine Software Companies in Global Market, by Revenue in 2021
3.5 Global Companies AI Medicine Software Product Type
3.6 Tier 1, Tier 2 and Tier 3 AI Medicine Software Players in Global Market
3.6.1 List of Global Tier 1 AI Medicine Software Companies
3.6.2 List of Global Tier 2 and Tier 3 AI Medicine Software Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global AI Medicine Software Market Size Markets, 2021 & 2028
4.1.2 Diagnosis Processes
4.1.3 Treatment Protocol Development
4.1.4 Drug Development
4.1.5 Personalized Medicine
4.1.6 Patient Monitoring and Care
4.2 By Type - Global AI Medicine Software Revenue & Forecasts
4.2.1 By Type - Global AI Medicine Software Revenue, 2017-2022
4.2.2 By Type - Global AI Medicine Software Revenue, 2023-2028
4.2.3 By Type - Global AI Medicine Software Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global AI Medicine Software Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 By Application - Global AI Medicine Software Revenue & Forecasts
5.2.1 By Application - Global AI Medicine Software Revenue, 2017-2022
5.2.2 By Application - Global AI Medicine Software Revenue, 2023-2028
5.2.3 By Application - Global AI Medicine Software Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global AI Medicine Software Market Size, 2021 & 2028
6.2 By Region - Global AI Medicine Software Revenue & Forecasts
6.2.1 By Region - Global AI Medicine Software Revenue, 2017-2022
6.2.2 By Region - Global AI Medicine Software Revenue, 2023-2028
6.2.3 By Region - Global AI Medicine Software Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America AI Medicine Software Revenue, 2017-2028
6.3.2 US AI Medicine Software Market Size, 2017-2028
6.3.3 Canada AI Medicine Software Market Size, 2017-2028
6.3.4 Mexico AI Medicine Software Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe AI Medicine Software Revenue, 2017-2028
6.4.2 Germany AI Medicine Software Market Size, 2017-2028
6.4.3 France AI Medicine Software Market Size, 2017-2028
6.4.4 U.K. AI Medicine Software Market Size, 2017-2028
6.4.5 Italy AI Medicine Software Market Size, 2017-2028
6.4.6 Russia AI Medicine Software Market Size, 2017-2028
6.4.7 Nordic Countries AI Medicine Software Market Size, 2017-2028
6.4.8 Benelux AI Medicine Software Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia AI Medicine Software Revenue, 2017-2028
6.5.2 China AI Medicine Software Market Size, 2017-2028
6.5.3 Japan AI Medicine Software Market Size, 2017-2028
6.5.4 South Korea AI Medicine Software Market Size, 2017-2028
6.5.5 Southeast Asia AI Medicine Software Market Size, 2017-2028
6.5.6 India AI Medicine Software Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America AI Medicine Software Revenue, 2017-2028
6.6.2 Brazil AI Medicine Software Market Size, 2017-2028
6.6.3 Argentina AI Medicine Software Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa AI Medicine Software Revenue, 2017-2028
6.7.2 Turkey AI Medicine Software Market Size, 2017-2028
6.7.3 Israel AI Medicine Software Market Size, 2017-2028
6.7.4 Saudi Arabia AI Medicine Software Market Size, 2017-2028
6.7.5 UAE AI Medicine Software Market Size, 2017-2028
7 Players Profiles
7.1 Enlitic
7.1.1 Enlitic Corporate Summary
7.1.2 Enlitic Business Overview
7.1.3 Enlitic AI Medicine Software Major Product Offerings
7.1.4 Enlitic AI Medicine Software Revenue in Global Market (2017-2022)
7.1.5 Enlitic Key News
7.2 Atomwise
7.2.1 Atomwise Corporate Summary
7.2.2 Atomwise Business Overview
7.2.3 Atomwise AI Medicine Software Major Product Offerings
7.2.4 Atomwise AI Medicine Software Revenue in Global Market (2017-2022)
7.2.5 Atomwise Key News
7.3 DeepMind
7.3.1 DeepMind Corporate Summary
7.3.2 DeepMind Business Overview
7.3.3 DeepMind AI Medicine Software Major Product Offerings
7.3.4 DeepMind AI Medicine Software Revenue in Global Market (2017-2022)
7.3.5 DeepMind Key News
7.4 Babylon Health
7.4.1 Babylon Health Corporate Summary
7.4.2 Babylon Health Business Overview
7.4.3 Babylon Health AI Medicine Software Major Product Offerings
7.4.4 Babylon Health AI Medicine Software Revenue in Global Market (2017-2022)
7.4.5 Babylon Health Key News
7.5 Flatiron Health
7.5.1 Flatiron Health Corporate Summary
7.5.2 Flatiron Health Business Overview
7.5.3 Flatiron Health AI Medicine Software Major Product Offerings
7.5.4 Flatiron Health AI Medicine Software Revenue in Global Market (2017-2022)
7.5.5 Flatiron Health Key News
7.6 Tempus Labs
7.6.1 Tempus Labs Corporate Summary
7.6.2 Tempus Labs Business Overview
7.6.3 Tempus Labs AI Medicine Software Major Product Offerings
7.6.4 Tempus Labs AI Medicine Software Revenue in Global Market (2017-2022)
7.6.5 Tempus Labs Key News
7.7 Sophia Genetics
7.7.1 Sophia Genetics Corporate Summary
7.7.2 Sophia Genetics Business Overview
7.7.3 Sophia Genetics AI Medicine Software Major Product Offerings
7.7.4 Sophia Genetics AI Medicine Software Revenue in Global Market (2017-2022)
7.7.5 Sophia Genetics Key News
7.8 Recursion Pharmaceuticals
7.8.1 Recursion Pharmaceuticals Corporate Summary
7.8.2 Recursion Pharmaceuticals Business Overview
7.8.3 Recursion Pharmaceuticals AI Medicine Software Major Product Offerings
7.8.4 Recursion Pharmaceuticals AI Medicine Software Revenue in Global Market (2017-2022)
7.8.5 Recursion Pharmaceuticals Key News
7.9 Synyi
7.9.1 Synyi Corporate Summary
7.9.2 Synyi Business Overview
7.9.3 Synyi AI Medicine Software Major Product Offerings
7.9.4 Synyi AI Medicine Software Revenue in Global Market (2017-2022)
7.9.5 Synyi Key News
7.10 Freenome
7.10.1 Freenome Corporate Summary
7.10.2 Freenome Business Overview
7.10.3 Freenome AI Medicine Software Major Product Offerings
7.10.4 Freenome AI Medicine Software Revenue in Global Market (2017-2022)
7.10.5 Freenome Key News
7.11 GNS Healthcare
7.11.1 GNS Healthcare Corporate Summary
7.11.2 GNS Healthcare Business Overview
7.11.3 GNS Healthcare AI Medicine Software Major Product Offerings
7.11.4 GNS Healthcare AI Medicine Software Revenue in Global Market (2017-2022)
7.11.5 GNS Healthcare Key News
7.12 Olive
7.12.1 Olive Corporate Summary
7.12.2 Olive Business Overview
7.12.3 Olive AI Medicine Software Major Product Offerings
7.12.4 Olive AI Medicine Software Revenue in Global Market (2017-2022)
7.12.5 Olive Key News
7.13 Ada Health
7.13.1 Ada Health Corporate Summary
7.13.2 Ada Health Business Overview
7.13.3 Ada Health AI Medicine Software Major Product Offerings
7.13.4 Ada Health AI Medicine Software Revenue in Global Market (2017-2022)
7.13.5 Ada Health Key News
7.14 Clarify Health Solutions
7.14.1 Clarify Health Solutions Corporate Summary
7.14.2 Clarify Health Solutions Business Overview
7.14.3 Clarify Health Solutions AI Medicine Software Major Product Offerings
7.14.4 Clarify Health Solutions AI Medicine Software Revenue in Global Market (2017-2022)
7.14.5 Clarify Health Solutions Key News
7.15 Sight Diagnostics
7.15.1 Sight Diagnostics Corporate Summary
7.15.2 Sight Diagnostics Business Overview
7.15.3 Sight Diagnostics AI Medicine Software Major Product Offerings
7.15.4 Sight Diagnostics AI Medicine Software Revenue in Global Market (2017-2022)
7.15.5 Sight Diagnostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|